Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life-Lite Clinical Trials Version.
Repository Usage Stats
The Impact of Weight on Quality of Life-Lite (IWQOL-Lite) is widely used in evaluations of weight-loss interventions, including pharmaceutical trials. Because this measure was developed using input from individuals undergoing intensive residential treatment, the IWQOL-Lite may include concepts not relevant to clinical trial populations and may be missing concepts that are relevant to these populations. An alternative version, the IWQOL-Lite Clinical Trials Version (IWQOL-Lite-CT), was developed and validated according to the US Food and Drug Administration's (FDA's) guidance on patient-reported outcomes. Psychometric analyses were conducted to validate the IWQOL-Lite-CT using data from two randomized trials (NCT02453711 and NCT02906930) that included individuals with overweight/obesity, with and without type 2 diabetes. Additional measures included the SF-36, global items, weight and body mass index. The IWQOL-Lite-CT is a 20-item measure with two primary domains (Physical [seven items] and Psychosocial [13 items]). A five-item Physical Function composite and Total score were also supported. Cronbach's alpha and intraclass correlation coefficients exceeded 0.77 at each time point; patterns of construct validity correlations were consistent with hypotheses; and scores demonstrated treatment benefit. The IWQOL-Lite-CT is appropriate for assessing weight-related physical and psychosocial functioning in populations commonly targeted for obesity clinical trials. Qualification from the FDA is being sought for use of the IWQOL-Lite-CT in clinical trials to support product approval and labelling claims.
SubjectImpact of Weight on Quality of Life-Lite (IWQOL-Lite)
Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT)
health-related quality of life
Published Version (Please cite this version)10.1111/cob.12310
Publication InfoKolotkin, Ronette; Williams, Valerie SL; Ervin, Claire M; Williams, Nicole; Meincke, Henrik H; Qin, Shanshan; ... Fehnel, Sheri E (2019). Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life-Lite Clinical Trials Version. Clinical obesity. pp. e12310. 10.1111/cob.12310. Retrieved from https://hdl.handle.net/10161/18534.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Consulting Professor in the Department of Family Medicine and Community Health
Research and practicing psychologist Developer of Impact of Weight on Quality of Life assessment tools for adults with obesity (IWQOL-Lite©) and adolescents with obesity (IWQOL-Kids©). Develop and test products, materials, and services for persons with obesityAssess and interpret quality of life data in pharmacological, surgical and other treatments of obesity and related illnesses Practicing psychologist: Eating and we
Showing items related by title, author, creator, and subject.
Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke. Britz, GW; Constable, M; Cox, M; Fonarow, GC; Lin, CB; Olson, DaiWai M; Peterson, Eric David; ... (9 authors) (J Am Heart Assoc, 2015-07-22)BACKGROUND: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless, the ability of US hospitals to meet guidelines for intravenous tissue plasminogen activator (tPA) remains suboptimal. What is unclear is ...
Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL). Denny, Thomas Norton; Garcia, Ambrosia; Sanchez, Ana M; Sarzotti-Kelsoe, Marcella; Todd, Christopher A (J Immunol Methods, 2014-07)The EQAPOL contract was awarded to Duke University to develop and manage global proficiency testing programs for flow cytometry-, ELISpot-, and Luminex bead-based assays (cytokine analytes), as well as create a genetically ...
Implementing a Continuous Quality Improvement Program in a High-Volume Clinical Echocardiography Laboratory: Improving Care for Patients With Aortic Stenosis. Armour, A; Douglas, Pamela Susan; Harrison, JK; Horan, Seanna; Kisslo, Joseph Andrew; Minter, Stephanie; Samad, Zainab; ... (12 authors) (Circ Cardiovasc Imaging, 2016-03)BACKGROUND: The management of aortic stenosis rests on accurate echocardiographic diagnosis. Hence, it was chosen as a test case to examine the utility of continuous quality improvement (CQI) approaches to increase ...